Estimated revenue of US$57 million to US$58 million, up 38.7% to 41.1% YOY Estimated gross profit of US$7.5 million to US$8 million, up 42.6% to 52.1% YOY SINGAPORE, March 9, 2026 -- YY Group Holding Limited (NASDAQ: YYGH) ("YY Group" or the "Company"), a global leader in on-demand workforce solutions and integrated facilities management (IFM), today announced preliminary and unaudited financial results for the fiscal year ended December 31, 2025. These results are subject to final review and will be confirmed when YY Group reports its Management's
ST. LOUIS, March 9, 2026 -- Seeger Weiss LLP, Motley Rice LLC, Waters Kraus Paul & Siegel, Williams Hart & Boundas LLP, The Holland Law Firm, and Ketchmark & McCreight P.C. announce that the Circuit Court of the City of St. Louis, State of Missouri, has granted preliminary approval of a proposed class action settlement of up to $7.25 billion in King v. Monsanto Company. The Court has preliminarily approved the settlement and authorized a comprehensive notice program to inform individuals who may be part of the Settlement Class of their rights and options. The proposed settl
セントルイス, 2026年3月9日 -- Seeger Weiss LLP、Motley Rice LLC、Waters Kraus Paul & Siegel、Williams Hart & Boundas LLP、The Holland Law Firm、およびKetchmark & McCreight P.C.は、 Circuit Court of the City of St. Louis, State of Missouriが、King v. Monsanto Company における最大72億5,000万ドルの集団訴訟の和解案を仮承認したことを発表しました。裁判所は和解案を仮承認し、和解クラスに属する可能性のある個人に対し、その権利と選択肢を通知する包括的な通知プログラムを承認しました。 提案されている和解案は、ラウンドアップ®やその他のグリホサート系除草剤への暴露が非ホジキンリンパ腫(NHL)を引き起こすという主張を解決するものです。非ホジキンリンパ腫は血液がんで、暴露後10年から15年を経て発症する場合があります。Monsantoは不正行為および責任に関するすべての申し立てを否定しています。裁判所は、請求の是非に関していかなる判断も下していません。 「今回の合意は、ラウンドアップに暴露された結果、非ホジキ
세인트루이스, 2026년 3월 9일 -- 미주리주 세인트루이스시 순회법원이 킹 대 몬산토 컴퍼니(King v. Monsanto Company) 사건에서 최대 미화 72억 5000만 달러 규모의 집단소송 합의안에 대해 예비 승인을 내렸음을 시거 바이스 LLP(Seeger Weiss LLP), 모틀리 라이스 LLC(Motley Rice LLC), 워터스 크라우스 폴 앤 시겔(Waters Kraus Paul & Siegel), 윌리엄스 하트 앤 바운다스 엘엘피(Williams Hart & Boundas LLP), 더 홀랜드 법률 사무소(The Holland Law Firm) 및 케치마크 앤 맥크레이트 P.C(Ketchmark & McCreight P.C.)가 발표했다. 법원은 합의안을 예비 승인하고, 합의 집단에 포함될 수 있는 개인들에게 권리와 선택 사항을 알리기 위한 포괄적인 통지 프로그램 시행을 승인했다. 이번 합의안은 Roundup® 및 기타 글리포세이트 기반 제초제 노출이 혈액암의 일종인 비호지킨 림프종(Non-Hodgkin Lymphoma, NHL)을 유발했다는 주장과 관련된 청구를 해결하기 위한 것이다. 해당
CHENGDU, China, March 9, 2026 -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) and Harbour BioMed (HKEX: 02142) today announced that the National Medical Products Administration (NMPA) of China has approved the Investigational New Drug (IND) application for SKB575/HBM7575, a long-acting bispecific antibody targeting thymic stromal lymphopoietin (TSLP) and an undisclosed target co-developed by the two parties, for the treatment of atopic dermatitis. Atopic dermatitis is a chronic, inflammatory skin
PARIS, NEW YORK and LONDON, March 9, 2026 -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), AMTD Digital Inc. (NYSE: HKD) and The Generation Essentials Group ("TGE", NYSE: TGE; LSE: TGE), a subsidiary of AMTD Digital Inc., jointly announce the successful completion of TGE's acquisition of the Hilton Garden Inn Hotel in New York City, Tribeca at US$69 Million. Located at 39 6th Ave, New York, NY 10013, the property is now rebranded as AMTD IDEA Tribeca Hotel (https://www.instagram.com/amtdideatribecahotel). Future plan has been announced to c
HO CHI MINH CITY, Vietnam, March 9, 2026 -- With an orientated development based on scientific nutrition, VitaDairy (Vietnam) has officially introduced its new ColosBaby Lactoferrin - a nutritional formula, which is utilized with many superior nutrients such as a super-immune complex Colostrum Protein Isolate IgHM. In particular, IgHM is a specialised ingredient comprising a group of antibodies structurally similar to those in breast milk. This is considered a breakthrough in the field of immunonutrition, promising to be a natural and superior source of immunonutrition. So, What is Ig
PETALING JAYA, Malaysia, March 9, 2026 -- Care Ventures Group (CVG) has announced a strategic investment in REN Health Sdn Bhd, positioning the company for its next phase as an AI-enabled women's wellness platform. REN develops herbal-based solutions targeting female-specific health concerns, including hormonal regulation, menstrual support, and postpartum recovery. With CVG's investment, the company will transition beyond product distribution into a technology-led, data-driven wellness model built for scale. Building Intelligent Infrastructure for Women's Health
STUART, Fla., March 9, 2026 -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2025, following the close of market on Wednesday, March 25, 2026. Health In Tech will host a conference call and live webcast to discuss the Company's financial results, recent developments and business outlook. Event: Health In Tech's Fourth Quarter and Full Year 2025 Earnings Conference Call When: Wednesday, March 25, 2026, at 5:00 p.m. ET Live Call:&nbs
GUIYANG, China, March 9, 2026 -- A news report from CNS: Shining on the Global Stage In recent years, a series of vibrant rural-themed "village" events in Guizhou, a province in southwest China, have gained immense popularity at home and abroad. Events such as the "Village Super League" football tournament, "Village BA" basketball game, "Village Marathon", "Village Spring Festival Gala", "Village Fashion Show" and "Village Dance Festival" have gone viral, emerging as new calling cards showcasing the vitality of Chin